Contrast agents

Photo

Breast cancer imaging

Should Gadolinium-based contrast agents be used in breast DTI?

The accuracy of breast cancer diagnosis via diffusion-tensor imaging (DTI) was equivalent both before and after the administration of a gadolinium-based contrast agent (GBCA), despite a value change in DTI parameters, finds a new research article. “However,” wrote first author Anabel M. Scaranelo of Princess Margaret Cancer Centre’s breast imaging division in Toronto, “the limitations in…

Photo

Future of contrast agents

Gadolinium in MRI is here to stay (at least for a while)

Manganese and iron oxide contrast agents can replace gadolinium-based contrast agents (GBCA) in a number of MRI examinations, but gadolinium remains a strong candidate when properly indicated, especially with AI-driven dose reduction and advances to increase relaxivity, a French expert explained at ECR 2020. GBCA have been MRI companions for many years. In France, 30% of all MR examinations are…

Photo

Increased usability and precision

New X-ray contrast agent enhances vascular imaging

Researchers at the University of Zurich have developed a new X-ray contrast agent which is easier to use and distributes into all blood vessels more reliably, increasing the precision of vascular imaging. This reduces the number of animals required in research experiments. Various diseases in humans and animals – such as tumors, strokes or chronic kidney disease – damage the blood vessels.…

Photo

Two-way magnetic resonance tuning

New double-contrast technique picks up small tumors on MRI

Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis, offers a significant advance in using magnetic resonance imaging (MRI) to pick out even very small tumors from normal tissue. The work is published in the journal Nature Nanotechnology. Chemical probes that produce a signal on MRI can be used to…

Photo

Enhancing cancer imaging

New contrast agent for early diagnosis of brain metastases

A group of researchers led by Leif Schröder from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) have found a way to detect metastases in certain types of cancer in the brain at an early stage, using only minimal amounts of contrast agent. To this end, the team uses a synthetic molecule that helps to detect the formation of new blood vessels, producing much more sophisticated…

Photo

Contrast agent in cola drinks

Gadolinium found in fast food restaurants

It has been found in many rivers and even in the tap water in some German cities, now scientists detected gadolinium from contrast agents in the food chain. A research group headed by Michael Bau, Professor of Geoscience at Jacobs University Bremen, detected the gadolinium in tap water and in cola soft drinks bought in restaurants of well-known fast-food franchises in Berlin, Dresden,…

Photo

Spotting scar muscles of the heart

New MRI technique saves kidneys from gadolinium damage

Traditional MRI (magnetic resonance imaging) scans use the metal gadolinium, which resonates areas of the heart muscles that are not functioning efficiently. However, gadolinium affects the Kidney function. A new 3D MRI computing technique developed by scientists at the University of Warwick calculates strain in heart muscles showing which muscles are not functioning enough without damaging other…

Photo

CEUS & the kidneys

Contrast-enhanced ultrasound for renal masses

Contrast enhanced ultrasound (CEUS) has proved in trials to be more accurate than computed tomography and MRI and can help eliminate the need for unnecessary biopsies and surgery. Led by Dr Richard Barr, Professor of Radiology at Northeast Ohio Medical University, the team has been using CEUS since 1999 and, for the specific study, focused on 721 patients referred for contrast-enhanced ultrasound…

Photo

GCCA/GBCA safety

Gadolinium @ ECR 2018 – diverse and “disunited”?

Gadolinium-containing/gadolinium-based contrast agents (GCCAs/GBCAs) and their usage was a major topic at ECR 2018. Fuelled by the current debate a number of presentations focused on possible impact, risks and necessities. Some were highly specific, others took a broader view. The only consensus, however, seems to be the need for more research and the focus on safety. Three ECR speakers, Joseph…

Photo

In the brain

Gadolinium deposition: A real threat or a phantom debate?

The European Medicines Agency (EMA) decided to suspend authorisation for certain linear gadolinium agents. The review by the Committee for Medicinal Products for Human Use (CHMP) states: “There is currently no evidence that gadolinium deposition in the brain has caused any harm to patients; however EMA has recommended restrictions and suspensions for some intravenous linear agents in order to…

Photo

Contrast agents

Reason must prevail in debates on GCCAs use

Radiologists must ensure precise scientific data and radiology-based evidence are used to regulate the use of Gadolinium Containing Contrast Agents (GCCAs), a Spanish leading radiologist explained in closed-door leadership meeting earlier this year in Barcelona.

Photo

Manganese or gadolinium?

Promising first steps for alternative MRI contrast agent

NIH-supported researchers at Massachusetts General Hospital (MGH) are studying an alternative to the contrast agents currently used for magnetic resonance imaging. In a recent study, they showed that the experimental alternative, a manganese-based compound, performs as well as approved contrast agents. Their study appeared online in Radiology. Magnetic resonance (MR) images are taken so that a…

Photo

Diverse benefits

Experts present CEUS insights

In April 2016 CEUS received the USA’s FDA approval. This year‘s RSNA Samsung Symposium ‘Contrast-Enhanced Ultrasound (CEUS): Innovations and a Problem-Solving Tool in Clinical Practice’ provided an opportunity to take stock. For European Hospital, Professor André Clevert, Director of the Interdisciplinary Centre for Ultrasound at University Hospital Munich, Germany, describes the current…

Photo

Technique comparison

Contrast-enhanced digital mammography vs. breast MRI

Contrast-enhanced digital mammography is comparable to breast MRI in evaluating residual breast cancer after neoadjuvant endocrine therapy or chemotherapy, according to the results of a study presented by Mayo Clinic researchers at the 2017 San Antonio Breast Cancer Symposium. “Our study aimed to compare contrast-enhanced mammography with breast MRI in evaluating residual breast cancer in…

Photo

CEUS

Advancing contrast enhanced ultrasound

The ability to demonstrate blood perfusion as well as organ function using contrast agentenhanced ultrasound is quickly finding innovative uses in clinical practice. Contrast-enhanced ultrasound (CEUS) has advanced rapidly since its first introduction. Today it is widely used as a primary imaging technique for a number of indications and pathologies. At a symposium organised by Bracco Imaging…

Photo

Gadolinium-based contrast agents

Clinicians define optimal approach for MRI contrast to maximize benefit

Gadolinium-based contrast agents are an essential component of MRI exams, but are challenged by findings of residual depositions of gadolinium in the body, even though the clinical relevance remains unknown. Three clinicians described how changes to MRI protocols and dose levels for contrast media can optimise the balance between benefit and risk for patients and radiologists.

Contrast agents

MultiHance receives approval for use in MRI of the whole body

Bracco Imaging S.p.A., a global leading company in the diagnostic imaging business, today announced the approval of the use of MultiHance® (gadobenate dimeglumine) in Magnetic Resonance Imaging (MRI) of the whole body in adults and paediatric patients (> 2 years). The approval was obtained through a Mutual Recognition Procedure, with the Medicines and Healthcare products Regulatory Agency…

Photo

The MAGiC

One Scan. Six contrasts. Triple Speed.

SIGNA Pioneer, a new 3.0 T ­Magnetic ­Resonance Imaging (MRI) system, ­embodies the exploration and expansion of modern medical imaging and blazes a trail to the future of MRI. Dr. Ahlers, general manager of radiomed, shares his experience with SIGNA Pioneer recently installed at radiomed practice in Wiesbaden, Germany – one of the ­first installations worldwide.

85 show more articles